The DZNE does not only conduct locally designed studies at the individual sites. Due to its structure, it is possible that subjects in multicenter studies can be examined at all participating DZNE…
Swarm Learning presented at HPE Discover 2024
"Swarm Learning is a revolutionary shift from sharing ai training and learnings and insights without sharing individual private data" said HPE…
PELI-D III - Preferences of people of Turkish origin with dementia in Germany: An intersectional perspective
Project overview
Duration: 2022-2026 Funding: DZNE …
PELI-D TP
Preferences regarding freetime activities for people with care needs in day care
Background
The organization and performance of freetime activities are associated with maintaining or…
The DZNE Foundation
The goal of the DZNE Foundation and its three endowment funds is to support research at the DZNE with the help of donations so that diseases such as dementia (e.g. Alzheimer's),…
"The decision is incomprehensible"
The European Medicines Agency (EMA) has recommended the refusal of the marketing authorization for the novel Alzheimer’s drug “Lecanemab” (brand name:…
MethodForum Witten
Background
The complexity of the phenomenon of dementia poses challenges for science and society. In addition to differentiated basic research and a variety of clinical…
back to overview
REALISE
General
The early detection of Alzheimer's disease using biomarkers is a prerequisite for the use of new antibody therapies in the treatment of the disease, which are…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
